Number of employees
15
Annual revenue
$1000000
GenPhar, Inc. is a biopharmaceutical company dedicated to becoming a leader in developing and producing prophylactic and therapeutic vaccines to protect against the world's most dangerous diseases.GenPhar’s scientists have developed a complex and adaptive, proprietary vaccine technology designed to develop multivalent vaccines (protects against multiple virus strains) .Successful, safe vaccination is the most effective way to prevent infectious diseases. GenPhar's multivalent vaccines have proven 100% safe and effective against the strictest of tests and standards conducted by the Department of Defense.